The LactMed® database contains information on drugs and other chemicals to which breastfeeding mothers may be exposed. It includes information on the levels of such substances in breast milk and infant blood, and the possible adverse effects in the nursing infant.
This FDA page provides an index of over 400 FDA approved drugs and their descriptions. Note that it does not include all FDA approved drugs, but shares other resources to find more information on drugs not included on the list.
SAMHSA offers evidence-based resources to help providers screen, diagnose, and deliver integrated care to patients with co-occurring disorders.
In this webinar, Drs. John Iskander and Suzanne Gilboa discuss what CDC and its partners are doing to reduce prenatal substance exposure and how screening and brief interventions may reduce prenatal substance exposure and improve the health of women and infants.
This screening device is often used as a way to begin discussion about drug and alcohol use. Any woman who answers yes to one or more questions should be referred for further assessment.
This revised version of the CRAFFT screening tool incorporates changes that enhance the sensitivity of this well-validated and widely-utilized adolescent substance use screening tool to accurately identify adolescents at risk for a substance use disorder. It also presents new recommended clinician talking points, informed by the latest science and clinician feedback.
The Tobacco, Alcohol, Prescription medication, and other Substance use (TAPS) Tool consists of a combined screening component (TAPS-1) followed by a brief assessment (TAPS-2) for those who screen positive.
This web page outlines policies on substance use during pregnancy, categorizing how these policies differ from state to state.
This Guide to meant to help health care teams recognize, rethink and remediate the stigma and bias of words commonly used in caring for people with the chronic disease of substance use disorder:
This resource offers background information and tips for providers on how to use person-first language and on which terms to avoid using to reduce stigma and negative bias when discussing addiction or substance use disorder with pregnant women and mothers.
Email Updates